Get the Stockscreener App
6.31
2.60%
0.16
After Hours:
6.31
Inogen Inc stock is traded at $6.31, with a volume of 191.64K.
It is up +2.60% in the last 24 hours and down -9.08% over the past month.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
See More
Previous Close:
$6.15
Open:
$6.24
24h Volume:
191.64K
Relative Volume:
0.62
Market Cap:
$170.84M
Revenue:
$351.50M
Net Income/Loss:
$-24.90M
P/E Ratio:
-6.8856
EPS:
-0.9164
Net Cash Flow:
$-10.24M
1W Performance:
-1.41%
1M Performance:
-9.08%
6M Performance:
+7.13%
1Y Performance:
-7.21%
1-Day Range:
$6.24
$6.45
1-Week Range:
$6.13
$6.6089
52-Week Range:
$5.3401
$9.13
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.31 | 166.51M | 351.50M | -24.90M | -10.24M | -0.9164 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Initiated | B. Riley Securities | Buy |
| May-22-25 | Upgrade | Needham | Hold → Buy |
| Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-23 | Downgrade | Needham | Buy → Hold |
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Inogen Inc (INGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inogen Inc (INGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inogen Inc (INGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
INGN|Inogen Inc|Price:6.150|Chg%:-0.170 - TradingKey
Inogen Inc (INGN) Balance Sheet - TradingKey
TradingKey - TradingKey
Inogen Inc (INGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inogen stock trades quietly as investors weigh margin pressure and restructuring impact - Ad-hoc-news.de
Inogen to report Q2 2026 results after market close, host conference call - Bitget
Inogen to report second quarter 2026 results on August 6 - scanx.trade
Press Release: Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026 - Moomoo
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire
Inogen Inc (INGN) Holds Steady Near Support as Consolidation ContinuesMFI Divergence - dars.gov.et
Inogen (INGN) Stifel 2024 Healthcare Conference Summary - Quartr
Form 4 Inogen Inc For: 9 July By Investing.com - Investing.com Nigeria
Inogen (INGN) EVP, COO awarded 130,000 restricted stock units vesting from 2026 - Stock Titan
Inogen (INGN) EVP, COO Andrew Reding files baseline Form 3 insider report - Stock Titan
Inogen Inc (INGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Inogen Inc (INGN) executive sells 10,938 shares in planned trade - Stock Titan
Inogen Inc (INGN) Slips Slightly Amidst Range-Bound TradingPrice Surge Stocks - dars.gov.et
INGNInogen Inc Volatility & Greeks - Finviz
Inogen (INGN) Proxy Filing Summary - Quartr
Inogen Appoints New Chief Operating Officer for Growth - The Globe and Mail
Inogen Announces the Appointment of Andy Reding as Chief Operating Officer - BioSpace
Inogen appoints Andy Reding as chief operating officer - Investing.com
[144] Inogen Inc SEC Filing - Stock Titan
Inogen (INGN) Appoints New COO to Enhance Operational Efficiency - GuruFocus
Inogen appoints Andy Reding as chief operating officer By Investing.com - Investing.com India
Inogen Appoints Reding to New COO Role - Moomoo
Inogen (Nasdaq: INGN) adds COO Andy Reding with equity package - Stock Titan
Inogen, Inc. Financial Disclosures & Filings - TradingView
Inogen Inc (INGN) Q1 2026 Earnings: EPS Miss Weighs on Shares as Revenue Details Remain DisclosedEarnings Surprise Score - dars.gov.et
Tranche Update on Inogen, Inc.'s Equity Buyback Plan announced on February 24, 2026. - marketscreener.com
Here's why you should retain Inogen stock in your portfolio for now - MSN
Inogen, Inc. Actuals & Estimates (NASDAQ:INGN) - TradingView
Inogen, Inc. Actuals & Estimates (LSX:A1XB32) - TradingView
Inogen, Inc. Actuals & Estimates (SWB:6IO) - TradingView
Enterprise value to EBIT forward of Inogen, Inc – NASDAQ:INGN - TradingView
Price to sales forward of Inogen, Inc – NASDAQ:INGN - TradingView
Enterprise value to revenue forward of Inogen, Inc – NASDAQ:INGN - TradingView
Inogen, Inc. Actuals & Estimates (GETTEX:6IO) - TradingView
INGN Forecast — Price Target — Prediction for 2027 - TradingView
6IO Forecast — Price Target — Prediction for 2027 - TradingView
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - Zacks Investment Research
INGN Q1 2026 Earnings: EPS Misses Estimates, Shares Edge HigherEstimate Dispersion - dars.gov.et
Precision Trading with Inogen Inc (INGN) Risk Zones - Stock Traders Daily
Inogen Inc (INGN) Institutional Confidence - TradingKey
Inogen Inc (INGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inogen Inc (INGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inogen Inc (INGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
INGN Q1 2026 Earnings: EPS Misses Estimates as Revenue Details UnavailableProfit Inflection Point - dars.gov.et
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):